All terms in HP

Label Id Description
Exacerbated by amiodarone exposure HP_0034962 [Applied to a sign or symptom that is worsened by treatment with amiodarone.]
Aggravated by exposure to medication HP_4000176 [Applied to a sign or symptom that is worsened by treatment with a medication.]
Ureteral mass HP_0034963 [A swelling or enlargement localized to the ureter. The word mass is usually used at an early stage of the diagnostic workup before the precise nature of the swelling has been determined.]
Stress urinary incontinence HP_0010992 [Involuntary urine leakage synchronous with exertion, or actions such as sneezing, or coughing.]
Wide cavum septum pellucidum HP_0034964 [Width of the cavum septum pellucidum above the upper limit of normal, which is defined as a separation of greater than one cm of the leaves of the cavum septum pellucidum.]
Kappa Bence Jones proteinuria HP_0032302 [The presence of free monoclonal kappa immunoglobulin light chains in the urine.]
Genital warts HP_0032301 [Warts affecting the skin in the genital area (penile shaft, scrotum, vagina, or labia majora). Warts can be small, beginning as a pinhead-size swelling that may become larger and take on a pedunculated appearance. Warts can spread and coalesce into large masses in the genital or anal area. Their color is variable but tends to be skin colored or darker, and they may occasionally bleed. Warts may cause itching, redness, or discomfort. An outbreak of genital warts may also cause psychological distress.]
Increased circulating IgG4 level HP_0032300 [An abnormally increased concentration of the IgG4 subtype in the blood circulation.]
Increased circulating IgG subclass HP_0032296 [An elevation of circulating IgG level predominantly related to an elevation of one of the four IgG subclasses.]
bone density conservation agent CHEBI_50646 [An agent that inhibits bone resorption and/or favor bone mineralization and bone regeneration. Used to heal bone fractures and to treat bone diseases such as osteopenia and osteoporosis.]
negative regulation of branching involved in lung morphogenesis GO_0061048 [Any process that decreases the rate, frequency, or extent of the process in which a highly ordered sequence of patterning events generates the branched structures of the lung, consisting of reiterated combinations of bud outgrowth, elongation, and dichotomous subdivision of terminal units.]
regulation of branching involved in lung morphogenesis GO_0061046 [Any process that modulates the rate, frequency, or extent of the process in which a highly ordered sequence of patterning events generates the branched structures of the lung, consisting of reiterated combinations of bud outgrowth, elongation, and dichotomous subdivision of terminal units.]
negative regulation of morphogenesis of an epithelium GO_1905331 [Any process that stops, prevents or reduces the frequency, rate or extent of morphogenesis of an epithelium.]
positive regulation of branching involved in lung morphogenesis GO_0061047 [Any process that increases the rate, frequency, or extent of the process in which a highly ordered sequence of patterning events generates the branched structures of the lung, consisting of reiterated combinations of bud outgrowth, elongation, and dichotomous subdivision of terminal units.]
positive regulation of morphogenesis of an epithelium GO_1905332 [Any process that activates or increases the frequency, rate or extent of morphogenesis of an epithelium.]
regulation of morphogenesis of a branching structure GO_0060688 [Any process that modulates the rate, frequency, or extent of branching morphogenesis, the process in which the anatomical structures of branches are generated and organized.]
regulation of morphogenesis of an epithelium GO_1905330 [Any process that modulates the frequency, rate or extent of morphogenesis of an epithelium.]
Retinal phlebitis HP_0020310 [Inflammation of retinal venules as manifested by perivascular sheathing or cuffing, vascular leakage and/or occlusion.]
Retinal vasculitis HP_0025188 [Inflammation of retinal blood vessels as manifested by perivascular sheathing or cuffing, vascular leakage and/or occlusion. It can affect veins, arteries or both.]
Ophthalmic artery hypoperfusion HP_0020311 [Chronic hypoperfusion due to large vessel disease e.g. carotid artery stenosis, Takayasu disease. Typically presents dilated veins, low retinal arterial pressure, peripheral microaneurysms, ocular hypotension and may lead to iris neovascularisation. Patients may have postural hypotension.]